No AccessFocus on olanzapine S Davis S Davis1 Search for more papers by this author Affiliations 1Amayeza Info Services, South Africa Published Online:1 Mar 2023https://doi.org/10.36303/SAGP.0172https://hdl.handle.net/10520/ejc-mp_sagp_v4_n2_a8SectionsPDFView Full Text ToolsAdd to favouritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InRedditGMailOutlookCopy LinkMendeley AboutAbstractOlanzapine is indicated for the management of manifestations of psychotic disorders, acute episodes of moderate to severe mania, and prevention of recurrence of manic or depressive episodes of bipolar disorder.1,21. Rossiter DSouth African Medicines Formulary14thCape TownSouth African Medical Association2022 Google Scholar2. Zyprexa (olanzapine tablets, VELOTAB and Powder for IM injection)Package Insert Eli Lilly (S.A.) (Pty) LimitedBryanston1Dec2006 Google Scholar3. "Olanzapine" MerativeTM Micromedex® DRUGDEX® (electronic version)MerativeAnn Arbor, Michigan, USAAvailable from: https://www.micromedexsolutions.com/Accessed 10 Feb 2023 Google Scholar4. Thomas KSaadabadi A "Olanzapine. Updated 8 Sept 2022" StatPearls [Internet]Treasure Island (FL)StatPearls Publishing2022JanAvailable from: https://www.ncbi.nlm.nih.gov/books/NBK532903/Accessed 10 Feb 2023 Google Scholar5. Bobo WVShelton RC "Bipolar major depression in adults: Efficacy and adverse effects of second-generation antipsychotics. Updated 1 Aug 2022" UpToDateAvailable from: https://www.uptodate.com/contents/bipolar-major-depression-in-adults-efficacy-and-adverse-effects-of-second-generation-antipsychoticsAccessed 10 Feb 2023 Google Scholar6. Zhang JPGallego JARobinson DGet al. "Efficacy and safety of individual second-generation vs first-generation antipsychotics in first episode psychosis: A systematic review and meta-analysis" Int J Neuropsychopharmacol2013 166120518 DOI: https://doi.org/10.1017/S1461145712001277 Google Scholar Previous article Next article FiguresReferencesRelatedDetails None Volume 4, Issue 2 | Mar 2023 Downloaded 6 times LanguagesEnglish InformationCopyright © 2023, Medpharm Publications:All rights reservedPDF download Disclosure The authors confirm that the manuscript has been read and approved by all named authors and that there are no other persons who satisfied the criteria for authorship but are not listed. The authors confirm that they have given due consideration to the protection of intellectual property associated with this work and that there are no impediments to publication, including the timing of publication, with respect to intellectual property. Ethical conduct of research The authors state that they have obtained appropriate institutional review board outlined in the Declaration of Helsinki for all human or animal experimental investigations. A signed informed consent document has been obtained from all participants included in the study.